Package 61958-3401-1

Brand: yeztugo

Generic: lenacapavir sodium
NDC Package

Package Facts

Identity

Package NDC 61958-3401-1
Digits Only 6195834011
Product NDC 61958-3401
Product ID 61958-3401_4fcd5eac-41a1-43cd-98c5-f733d5094ff9
Description

4 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (61958-3401-1)

Marketing

Marketing Status
Marketed Since 2025-06-18
Brand yeztugo
Generic lenacapavir sodium
Sample Package No

Linked Drug Pages (1)

Yeztugo ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "4fcd5eac-41a1-43cd-98c5-f733d5094ff9", "openfda": {"unii": ["BDT58WJ9WE"], "rxcui": ["2625890", "2625904", "2625911", "2717197", "2717201", "2717203"], "spl_set_id": ["1c241af1-ce62-4b0a-9eb7-f6b626174f01"], "manufacturer_name": ["Gilead Sciences, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "4 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (61958-3401-1)", "package_ndc": "61958-3401-1", "marketing_start_date": "20250618"}], "brand_name": "Yeztugo", "product_id": "61958-3401_4fcd5eac-41a1-43cd-98c5-f733d5094ff9", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Breast Cancer Resistance Protein Inhibitors [MoA]", "Cytochrome P450 3A Inhibitors [MoA]", "HIV Capsid Inhibitors [MoA]", "Human Immunodeficiency Virus 1 Capsid Inhibitor [EPC]", "P-Glycoprotein Inhibitors [MoA]"], "product_ndc": "61958-3401", "generic_name": "LENACAPAVIR SODIUM", "labeler_name": "Gilead Sciences, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Yeztugo", "active_ingredients": [{"name": "LENACAPAVIR SODIUM", "strength": "300 mg/1"}], "application_number": "NDA220020", "marketing_category": "NDA", "marketing_start_date": "20250618", "listing_expiration_date": "20271231"}